These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12786637)

  • 1. Serotonergic modulators in the treatment of irritable bowel syndrome: influence on psychiatric and gastrointestinal symptoms.
    Castle MZ; Silk DB; Libby GW
    Aliment Pharmacol Ther; 2003 Jun; 17(11):1425. PubMed ID: 12786637
    [No Abstract]   [Full Text] [Related]  

  • 2. Systematic review: serotonergic modulators in the treatment of irritable bowel syndrome--influence on psychiatric and gastrointestinal symptoms.
    Kilkens TO; Honig A; Rozendaal N; Van Nieuwenhoven MA; Brummer RJ
    Aliment Pharmacol Ther; 2003 Jan; 17(1):43-51. PubMed ID: 12492731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on irritable bowel syndrome.
    Bergmann KA
    Postgrad Med J; 2003 Dec; 79(938):715. PubMed ID: 14707260
    [No Abstract]   [Full Text] [Related]  

  • 4. [Soon one "female distress" less. Irritable bowel syndrome responds to serotonin blockers].
    MMW Fortschr Med; 2000 Sep; 142(37):55. PubMed ID: 11026224
    [No Abstract]   [Full Text] [Related]  

  • 5. Neurotransmitter antagonism in management of irritable bowel syndrome.
    Lembo T
    Lancet; 2000 Mar; 355(9209):1030-1. PubMed ID: 10744083
    [No Abstract]   [Full Text] [Related]  

  • 6. New drugs to treat irritable bowel syndrome being tested.
    Mayo Clin Health Lett; 2000 Mar; 18(3):4. PubMed ID: 10734837
    [No Abstract]   [Full Text] [Related]  

  • 7. Alosetron for irritable bowel syndrome.
    Barbehenn E; Lurie P; Wolfe SM
    Lancet; 2000 Dec; 356(9246):2009-10. PubMed ID: 11130544
    [No Abstract]   [Full Text] [Related]  

  • 8. [Irritable bowel syndrome: diagnostic criteria and recent advancement of its pharmacological management].
    Matsueda K
    Nihon Shokakibyo Gakkai Zasshi; 2001 Oct; 98(10):1146-53. PubMed ID: 11680988
    [No Abstract]   [Full Text] [Related]  

  • 9. Alosetron: a new therapy for irritable bowel syndrome.
    Kupecz D
    Nurse Pract; 2000 Jul; 25(7):95-6, 98-100. PubMed ID: 10916831
    [No Abstract]   [Full Text] [Related]  

  • 10. Serotonin receptor modulation in irritable bowel syndrome: one step forwards and one step backwards.
    Whorwell PJ
    Gut; 2001 May; 48(5):596-7. PubMed ID: 11302953
    [No Abstract]   [Full Text] [Related]  

  • 11. Irritable bowel syndrome. New treatment drug on the market.
    Harv Health Lett; 2000 Jun; 25(8):7. PubMed ID: 10810051
    [No Abstract]   [Full Text] [Related]  

  • 12. Irritable bowel syndrome and the role of 5-HT. Proceedings of a roundtable meeting. New Orleans, Louisiana, USA. May 1998.
    Aliment Pharmacol Ther; 1999 May; 13 Suppl 2():1-82. PubMed ID: 10447353
    [No Abstract]   [Full Text] [Related]  

  • 13. Tegaserod and other serotonergic agents: what is the evidence?
    Chey WD
    Rev Gastroenterol Disord; 2003; 3 Suppl 2():S35-40. PubMed ID: 12776001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serotonin may be the key to the treatment of "irritable bowel disease"].
    Sjövall H
    Lakartidningen; 2001 May; 98(18):2166-71. PubMed ID: 11402594
    [No Abstract]   [Full Text] [Related]  

  • 15. [New therapeutic approaches in irritable bowel syndrome].
    Müller-Lissner SA
    Z Gastroenterol; 2000 Sep; 38(9):815-6. PubMed ID: 11072681
    [No Abstract]   [Full Text] [Related]  

  • 16. Alosetron approved for treatment of irritable bowel syndrome.
    Miller JL
    Am J Health Syst Pharm; 2000 Mar; 57(6):519. PubMed ID: 10754758
    [No Abstract]   [Full Text] [Related]  

  • 17. Alosetron in irritable bowel syndrome.
    McColl KE
    Lancet; 2000 Jul; 356(9224):164-5. PubMed ID: 10963271
    [No Abstract]   [Full Text] [Related]  

  • 18. Alosetron (Lotronex) for treatment of irritable bowel syndrome.
    Med Lett Drugs Ther; 2000 Jun; 42(1081):53-4. PubMed ID: 10872030
    [No Abstract]   [Full Text] [Related]  

  • 19. Selective 5-hydroxytryptamine antagonism: a role in irritable bowel syndrome and functional dyspepsia?
    Maxton DG; Morris J; Whorwell PJ
    Aliment Pharmacol Ther; 1996 Aug; 10(4):595-9. PubMed ID: 8853764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel medications for the irritable bowel syndrome: motility and sensation.
    Camilleri M
    J Pediatr Gastroenterol Nutr; 2001; 32 Suppl 1():S35-7. PubMed ID: 11321419
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.